DK0781560T3 - Anvendelse af immunoglobulinpræparater til fremstilling af et medikament til oral indgivelse til behandling og forebyggelse - Google Patents

Anvendelse af immunoglobulinpræparater til fremstilling af et medikament til oral indgivelse til behandling og forebyggelse

Info

Publication number
DK0781560T3
DK0781560T3 DK96119832T DK96119832T DK0781560T3 DK 0781560 T3 DK0781560 T3 DK 0781560T3 DK 96119832 T DK96119832 T DK 96119832T DK 96119832 T DK96119832 T DK 96119832T DK 0781560 T3 DK0781560 T3 DK 0781560T3
Authority
DK
Denmark
Prior art keywords
treatment
oral administration
medicament
prevention
manufacture
Prior art date
Application number
DK96119832T
Other languages
Danish (da)
English (en)
Inventor
Guenter Sprotte
Helge Karch
Reinhard Lissner
Wolfgang Moeller
Original Assignee
Biotest Pharma Gmbh
Helge Karch
Guenter Sprotte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotest Pharma Gmbh, Helge Karch, Guenter Sprotte filed Critical Biotest Pharma Gmbh
Application granted granted Critical
Publication of DK0781560T3 publication Critical patent/DK0781560T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1207—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/121—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Helicobacter (Campylobacter) (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/833—Whey; cheese

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK96119832T 1995-12-22 1996-12-11 Anvendelse af immunoglobulinpræparater til fremstilling af et medikament til oral indgivelse til behandling og forebyggelse DK0781560T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19548221A DE19548221C1 (de) 1995-12-22 1995-12-22 Orale Anwendung von Immunglobulin-Präparationen zur Behandlung und Prophylaxe chronischer Schmerzzustände

Publications (1)

Publication Number Publication Date
DK0781560T3 true DK0781560T3 (da) 2000-11-13

Family

ID=7781069

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96119832T DK0781560T3 (da) 1995-12-22 1996-12-11 Anvendelse af immunoglobulinpræparater til fremstilling af et medikament til oral indgivelse til behandling og forebyggelse

Country Status (6)

Country Link
US (1) US5871731A (fr)
EP (1) EP0781560B1 (fr)
AT (1) ATE196738T1 (fr)
DE (2) DE19548221C1 (fr)
DK (1) DK0781560T3 (fr)
ES (1) ES2152479T3 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985356A (en) 1994-10-18 1999-11-16 The Regents Of The University Of California Combinatorial synthesis of novel materials
JP3430853B2 (ja) 1997-04-11 2003-07-28 株式会社ゲン・コーポレーション 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤
JP2000351735A (ja) * 1999-04-09 2000-12-19 Akzo Nobel Nv カンピロバクターワクチン
US20040202660A1 (en) * 2001-01-30 2004-10-14 Joy Campbell Methods and compositions for treatment of immune dysfunction disorders
EP1357943A2 (fr) * 2001-01-30 2003-11-05 The Lauridsen Group Incorporated Procedes et compositions destines a moduler le systeme immunitaire des animaux
US20030099633A1 (en) * 2001-10-09 2003-05-29 Campbell Joy M. Methods and compositions for treatment of immune dysfunction disorders
US20030103962A1 (en) * 2001-10-09 2003-06-05 Campbell Joy M. Methods and compositions for modulating the immune system of animals
US7244427B2 (en) * 2001-01-30 2007-07-17 The Lauridsen Group Incorporated Isolated bovine IgG heavy chain protein and its use as an antimicrobial
US20030190314A1 (en) * 2001-01-30 2003-10-09 The Lauridsen Group Methods and compositions of treatment for modulating the immune system of animals
US6939954B2 (en) * 2001-01-30 2005-09-06 The Lauridsen Group Incorporated Isolated bovine lgG heavy chain protein and its use as an antimicrobial
US6912515B2 (en) * 2001-06-04 2005-06-28 Xerox Corporation Method and system for algorithm synthesis in problem solving
JP2008540462A (ja) * 2005-05-10 2008-11-20 マレー ゴールバーン コーオペラティブ コー リミテッド 免疫グロブリン分画およびそのためのプロセス
DE102011006809A1 (de) 2011-04-05 2012-10-11 Freistaat Bayern vertreten durch die Julius-Maximilians-Universität Würzburg Verwendung eines Mittels aus Antikörpern und/oder Insulin-like growth factor-Antagonisten
US10716850B2 (en) 2014-12-31 2020-07-21 Wellin, Inc. Anti-inflammatory factor retentate, method of isolation, and use
US10478493B2 (en) 2015-08-31 2019-11-19 Stolle Milk Biologics, Inc. Method of treating protozoal gastrointestinal disorders in immunocompromised patients

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
USRE33565E (en) * 1978-02-06 1991-04-02 Stolle Research And Development Corporation Prevention and treatment of rheumatioid arthritis
US4756907A (en) * 1978-10-17 1988-07-12 Stolle Research & Development Corp. Active/passive immunization of the internal female reproductive organs
US4585651A (en) * 1978-10-17 1986-04-29 Stolle Research & Development Corporation Active/passive immunization of the internal female reproductive organs
US5242691A (en) * 1982-06-03 1993-09-07 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5352462A (en) * 1982-06-03 1994-10-04 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5066491A (en) * 1985-04-15 1991-11-19 Protein Technology, Inc. Method of disease treatment utilizing an immunologically active whey fraction
US4843065A (en) * 1985-05-22 1989-06-27 Collins Robert A Method of producing products for use in the treatment of bacterial and/or virus infections
DE3689717T2 (de) * 1985-11-25 1994-10-20 Gen Corp Kk Einen spezifischen Antikörper enthaltender Stoff aus Eiern, Verfahren zu dessen Herstellung und seine Anwendung.
US5106618A (en) * 1987-07-02 1992-04-21 Stolle Research And Development Corporation Method of treating protozoal gastrointestinal disorders by administering hyperimmune milk product
EP0338229B1 (fr) * 1988-04-19 1993-06-16 Biotest Pharma Gmbh Préparation à activité d'anticorps et large spectre d'action, remède constitué par ou la contenant et son utilisation pour le traitement de maladies bactériennes ou induites par des toxines et pour lutter contre les protozoaires
IE76730B1 (en) * 1990-07-30 1997-11-05 Abbott Laboraties Method and product for the treatment of gastric disease
CA2097426A1 (fr) * 1990-11-30 1992-05-31 Bruce M. Cameron, Sr. Methode de diagnostic de douleurs lombaires et cervicales chroniques
US5420253A (en) * 1993-09-09 1995-05-30 Willmar Poultry Company, Inc. Method for purifying egg yolk immunoglobulins
US5558993A (en) * 1994-06-17 1996-09-24 The Regents Of The University Of California Cloned Borrelia burgdorferi virulence protein
US5531988A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Bacteria and immunoglobulin-containing composition for human gastrointestinal health
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
AUPN115095A0 (en) * 1995-02-15 1995-03-09 Butt, Henry Lawrence Analysis of and compositions and methods for the treatment of disease

Also Published As

Publication number Publication date
EP0781560B1 (fr) 2000-10-04
DE19548221C1 (de) 1997-05-15
EP0781560A1 (fr) 1997-07-02
ES2152479T3 (es) 2001-02-01
DE59605959D1 (de) 2000-11-09
ATE196738T1 (de) 2000-10-15
US5871731A (en) 1999-02-16

Similar Documents

Publication Publication Date Title
DK0781560T3 (da) Anvendelse af immunoglobulinpræparater til fremstilling af et medikament til oral indgivelse til behandling og forebyggelse
NO20053105D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse for administrering ±n gang pr. dag.
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
NL1003300A1 (nl) Implanteerbare therapeutische inrichting.
FI923273A0 (fi) Med dubbelminne foersett multiprocessorsystem.
LV11615A (lv) Amidi ar arstnieciskam ipasibam
DE3680943D1 (de) Therapeutische mittel zur oralen verabreichung.
MX9205981A (es) Administracion transdermica de melatonina.
DK0668763T3 (da) Anvendelse af phenserin til fremstillingen af lægemidler til behandlingen af kognitive sygdomme
DK0998287T3 (da) Anvendelse af levobupivacain
DE59204364D1 (de) Zahnärztlicher Patientenstuhl.
DE59009354D1 (de) Zahnärztlicher Patientenstuhl.
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
DK0501705T3 (da) Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje
DE69200711D1 (de) Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung.
EP0744176A3 (fr) Médicaments pour inhiber les pertes osseuses
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
IT1288399B1 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
DE59508725D1 (de) Arztlicher, insbesondere zahnärztlicher Behandlungsstuhl
NO920640L (no) Anordning for terapeutisk trykkbehandling
DK236489A (da) Anvendelse af diazepinoner til terapeutisk behandling af mikrokredsloebsforstyrrelser
DK86093D0 (da) Praeparat til medikamentel behandling for tandlaegebrug mod lidelserne tandkoedsbetaendelse og tandnervebetaendelse
NO974941L (no) Ny anvendelse av (S)-adenosyl-L-metionin(SAMe)
ES1019006Y (es) Jeringa de anestesia dental desechable.